会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Process for producing 2-O-alpha-D-glucopyranosyl-L-ascorbic acid
    • 制备2-O-α-D-吡喃葡萄糖基-L-抗坏血酸的方法
    • US08759030B2
    • 2014-06-24
    • US10523920
    • 2003-07-07
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • C12P19/44
    • C12P19/60
    • The object of the present invention is to provide a method and a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid where 5-O-α-glucopyranosyl-L-ascorbic acid and 6-O-α-glucopyranosyl-L-ascorbic acid are not formed or formed in such a small amount that the formation of these can nor be detected. The present invention solves the above object by providing a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid comprising the steps of allowing α-isomaltosyl glucosaccharide-forming enzyme together with or without cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on a solution comprising L-ascorbic acid and, an α-glucosyl saccharide to form 2-O-α-glucopyranosyl-L-ascorbic acid and collecting the formed 2-O-α-glucopyranosyl-L-ascorbic acid.
    • 本发明的目的是提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法和方法,其中5-O-α-吡喃葡萄糖基-L-抗坏血酸和6-O-α-吡喃葡萄糖基 - L-抗坏血酸不是以这样的少量形成或形成,也可以不形成。 本发明通过提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法来解决上述目的,其包括以下步骤:将α-异麦芽糖基葡萄糖形成酶与或不与环糊精葡聚糖转移酶(EC 2.4.1.19)一起 作用于包含L-抗坏血酸和α-葡萄糖基糖的溶液中以形成2-O-α-吡喃葡萄糖基-L-抗坏血酸并收集形成的2-O-α-吡喃葡萄糖基-L-抗坏血酸。
    • 7. 发明申请
    • Process for producing 2-0-alpha-d-glucopyranosyl-l-ascorbic acid
    • 制备2-0-α-d-吡喃葡萄糖基-1-抗坏血酸的方法
    • US20060216792A1
    • 2006-09-28
    • US10523920
    • 2003-07-07
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • C12P19/44
    • C12P19/60
    • The object of the present invention is to provide a method and a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid where 5-O-α-glucopyranosyl-L-ascorbic acid and 6-O-α-glucopyranosyl-L-ascorbic acid are not formed or formed in such a small amount that the formation of these can nor be detected. The present invention solves the above object by providing a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid comprising the steps of allowing α-isomaltosyl glucosaccharide-forming enzyme together with or without cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on a solution comprising L-ascorbic acid and, an α-glucosyl saccharide to form 2-O-α-glucopyranosyl-L-ascorbic acid and collecting the formed 2-O-α-glucopyranosyl-L-ascorbic acid.
    • 本发明的目的是提供一种生产2-O-α-glucopyranosyl-L-抗坏血酸的方法和方法,其中5-O-α-吡喃葡萄糖基-L-抗坏血酸和6-O-α-吡喃葡萄糖基-L- L-抗坏血酸不是以这样的少量形成或形成,也可以不形成。 本发明通过提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法来解决上述目的,其包括以下步骤:将α-异麦芽糖基糖糖形成酶与或不与环糊精葡聚糖转移酶(EC 2.4.1.19)一起使用 作用于包含L-抗坏血酸和α-葡糖基糖的溶液以形成2-O-α-吡喃葡萄糖基-L-抗坏血酸并收集形成的2-O-α-吡喃葡萄糖基-L-抗坏血酸。